[go: up one dir, main page]

NO20013409D0 - Use of pyrimidine derivatives for the prevention and treatment of cerebral ischemia - Google Patents

Use of pyrimidine derivatives for the prevention and treatment of cerebral ischemia

Info

Publication number
NO20013409D0
NO20013409D0 NO20013409A NO20013409A NO20013409D0 NO 20013409 D0 NO20013409 D0 NO 20013409D0 NO 20013409 A NO20013409 A NO 20013409A NO 20013409 A NO20013409 A NO 20013409A NO 20013409 D0 NO20013409 D0 NO 20013409D0
Authority
NO
Norway
Prior art keywords
prevention
treatment
cerebral ischemia
pyrimidine derivatives
pyrimidine
Prior art date
Application number
NO20013409A
Other languages
Norwegian (no)
Other versions
NO20013409L (en
Inventor
Gerd Steinler
Kurt Schellhaas
Wilfried Lubisch
Uta Holzenkamp
Dorothea Starck
Monika Knopp
Laszlo Szabo
Franz Emling
Francisco-Javier Garcia-Ladona
Hans Peter Hofmann
Liliane Unger
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of NO20013409D0 publication Critical patent/NO20013409D0/en
Publication of NO20013409L publication Critical patent/NO20013409L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20013409A 1999-01-11 2001-07-10 Use of pyrimidine derivatives for the prevention and treatment of cerebral ischemia NO20013409L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19900545A DE19900545A1 (en) 1999-01-11 1999-01-11 Use of pyrimidine derivatives for the prophylaxis and therapy of cerebral ischemia
PCT/EP1999/010369 WO2000041695A1 (en) 1999-01-11 1999-12-24 Utilization of pyrimidine derivatives for preventing and treating cerebral ischaemia

Publications (2)

Publication Number Publication Date
NO20013409D0 true NO20013409D0 (en) 2001-07-10
NO20013409L NO20013409L (en) 2001-08-30

Family

ID=7893836

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013409A NO20013409L (en) 1999-01-11 2001-07-10 Use of pyrimidine derivatives for the prevention and treatment of cerebral ischemia

Country Status (24)

Country Link
US (1) US6387912B1 (en)
EP (1) EP1140096A1 (en)
JP (1) JP2002534465A (en)
KR (1) KR20010101442A (en)
CN (1) CN1334732A (en)
AU (1) AU2433800A (en)
BG (1) BG105689A (en)
BR (1) BR9916887A (en)
CA (1) CA2359253A1 (en)
CZ (2) CZ20012484A3 (en)
DE (1) DE19900545A1 (en)
HK (1) HK1042649A1 (en)
HU (1) HUP0201149A3 (en)
ID (1) ID30022A (en)
IL (1) IL144146A0 (en)
MX (1) MXPA01006967A (en)
MY (1) MY133107A (en)
NO (1) NO20013409L (en)
NZ (1) NZ512767A (en)
PL (1) PL348920A1 (en)
SK (1) SK9692001A3 (en)
TR (1) TR200102008T2 (en)
WO (1) WO2000041695A1 (en)
ZA (1) ZA200105475B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19900673A1 (en) 1999-01-11 2000-07-13 Basf Ag Use of binding partners for 5-HT5 receptors for the treatment of neurodegenerative and neuropsychiatric disorders
US6988199B2 (en) * 2000-07-07 2006-01-17 Message Secure Secure and reliable document delivery
JP4548882B2 (en) * 1999-11-30 2010-09-22 興和創薬株式会社 4,5,6,7-tetrahydrothieno [2,3-c] pyridine compound
DE10031389A1 (en) * 2000-07-03 2002-01-17 Knoll Ag Pyrimidine derivatives and their use for the prophylaxis and therapy of cerebral ischemia
DE10031390A1 (en) * 2000-07-03 2002-01-17 Knoll Ag Pyrimidine derivatives and their use for the prophylaxis and therapy of cerebral ischemia
DE10259382A1 (en) * 2002-12-18 2004-07-01 Abbott Gmbh & Co. Kg 3-Substituted 3,4-dihydro-thieno [2,3-d] pyrimidin-4-one derivatives, their preparation and use
CA2685753A1 (en) * 2007-05-09 2008-11-20 Neuromed Pharmaceuticals Ltd. Bicyclic pyrimidine derivatives as calcium channel blockers
US8927718B2 (en) 2009-08-26 2015-01-06 Takeda Pharmaceutical Company Limited Fused heterocyclic ring derivative and use thereof
WO2021257857A1 (en) 2020-06-19 2021-12-23 Incyte Corporation Naphthyridinone compounds as jak2 v617f inhibitors
US11753413B2 (en) 2020-06-19 2023-09-12 Incyte Corporation Substituted pyrrolo[2,1-f][1,2,4]triazine compounds as JAK2 V617F inhibitors
CA3188639A1 (en) 2020-07-02 2022-01-06 Incyte Corporation Tricyclic urea compounds as jak2 v617f inhibitors
WO2022006456A1 (en) 2020-07-02 2022-01-06 Incyte Corporation Tricyclic pyridone compounds as jak2 v617f inhibitors
WO2022046989A1 (en) 2020-08-27 2022-03-03 Incyte Corporation Tricyclic urea compounds as jak2 v617f inhibitors
US11919908B2 (en) 2020-12-21 2024-03-05 Incyte Corporation Substituted pyrrolo[2,3-d]pyrimidine compounds as JAK2 V617F inhibitors
EP4298099A1 (en) 2021-02-25 2024-01-03 Incyte Corporation Spirocyclic lactams as jak2 v617f inhibitors
JP2025509672A (en) 2022-03-17 2025-04-11 インサイト・コーポレイション Tricyclic urea compounds as JAK2 V617F inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670560A (en) 1986-04-28 1987-06-02 Ortho Pharmaceutical Corporation Thienopyrimidine-2,4-dione derivatives and intermediates thereof
DE19636769A1 (en) 1996-09-10 1998-03-12 Basf Ag 3-Substituted pyrido [4 ', 3': 4,5] thieno [2,3-d] pyrimidine derivatives, their preparation and use
DE19724980A1 (en) 1997-06-13 1998-12-17 Basf Ag 3-Substituted 3,4-dihydro-thieno [2,3-d] pyrimidine derivatives, their preparation and use
DE19724979A1 (en) 1997-06-13 1998-12-17 Basf Ag 3-Substituted pyrido [3,4,5] thieno [2,3-d] pyrimidine derivatives, their preparation and use

Also Published As

Publication number Publication date
WO2000041695A1 (en) 2000-07-20
TR200102008T2 (en) 2001-12-21
PL348920A1 (en) 2002-06-17
ID30022A (en) 2001-11-01
NO20013409L (en) 2001-08-30
IL144146A0 (en) 2002-05-23
MXPA01006967A (en) 2002-04-10
BG105689A (en) 2002-02-28
DE19900545A1 (en) 2000-07-13
US6387912B1 (en) 2002-05-14
CA2359253A1 (en) 2000-07-20
EP1140096A1 (en) 2001-10-10
BR9916887A (en) 2001-11-20
AU2433800A (en) 2000-08-01
HUP0201149A3 (en) 2003-07-28
CZ20012484A3 (en) 2002-05-15
CZ20012485A3 (en) 2002-04-17
MY133107A (en) 2007-10-31
HK1042649A1 (en) 2002-08-23
NZ512767A (en) 2003-05-30
ZA200105475B (en) 2002-10-03
SK9692001A3 (en) 2002-05-09
HUP0201149A2 (en) 2002-07-29
JP2002534465A (en) 2002-10-15
KR20010101442A (en) 2001-11-14
CN1334732A (en) 2002-02-06

Similar Documents

Publication Publication Date Title
NO20014046D0 (en) Gabapentin derivatives for the prevention and treatment of visceral pain
NO20021474D0 (en) Compounds for the treatment of ischemia
NO20014379L (en) Use of Xenon for the Treatment of Neurointoxics
NO20013409D0 (en) Use of pyrimidine derivatives for the prevention and treatment of cerebral ischemia
NO20013369D0 (en) Arylpiperazinyl-cyclohexyl-indole derivatives for the treatment of depression
NO20013380D0 (en) 2-aminobenzoxazinone derivatives for the treatment of obesity
AU6048201A (en) Quinazoline derivatives for the treatment of tumours
HUP0302719A3 (en) Substituted amine derivatives and their use for the treatment of angiogenesis
NO20013381D0 (en) 2-oxybenzoxazinone derivatives for the treatment of obesity
NO20021400L (en) Therapeutic quinazoline derivatives
NO20022585D0 (en) Pyrrolidine acetamide derivative alone or in combination for the treatment of CNS disorders
IL155589A0 (en) Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
NO20024775D0 (en) Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
NO20032636D0 (en) 3-indoline derivatives useful in the treatment of psychiatric and neurological disorders
NO20015542L (en) Process for the preparation and use of N-desmethylzopiclones
IL145301A0 (en) 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of cns disorders
AU2001279709A1 (en) Pyrimidine derivatives and their use for preventing and treating cerebral ischaemia
NO20024777D0 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
NO20024776L (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
PT1152756E (en) USEFUL ANTICONVULSIVE DERIVATIVES IN THE TREATMENT OF AUTISM
NO20020784D0 (en) Medication for the treatment of fractures
NO20012541D0 (en) Use of phosphonomauric acid derivatives for the treatment of infections
NO20013651D0 (en) Use of phosphorus inorganic compounds for the prophylactic and therapeutic treatment of infections
NO20013408D0 (en) Use of 2-substituted 1,2-benzisothiazole derivatives and 3-substituted tetrahydropyridopyrimidinone derivatives for prophylaxis and therapy of cerebral ischemia
AU1028501A (en) Isoquinoline and quinazoline derivatives for the treatment of cns disorders

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application